Showing 1 - 2 results of 2 for search 'Erika P. Hamilton', query time: 0.02s Refine Results
  1. 1
    Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

    Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists by Hope S. Rugo, Aditya Bardia, William J. Gradishar, Erika P. Hamilton, Sara A. Hurvitz, Komal Jhaveri, Reshma Mahtani, Sara M. Tolaney

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2− advanced or metastatic breast cancer: phase 1/2 study results

    Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2− advanced or metastatic breast c... by Erika P. Hamilton, Manish R. Patel, Virginia F. Borges, Jane L. Meisel, Meena Okera, Carlos A. Alemany, Timothy J. Pluard, Robert Wesolowski, Dhanusha Sabanathan, Kathy D. Miller, Alison K. Conlin, Nicole McCarthy, Morena Shaw, Margaret Tonda, Mark Shilkrut, Nancy U. Lin

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: